Shareef, Sarah J.
Bevill, Samantha M.
Raman, Ayush T.
Aryee, Martin J. http://orcid.org/0000-0002-6848-1344
van Galen, Peter http://orcid.org/0000-0002-0735-1570
Hovestadt, Volker http://orcid.org/0000-0002-3480-6649
Bernstein, Bradley E. http://orcid.org/0000-0002-5726-6278
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (T32GM007753)
Human Frontier Science Program (LT000596/2016-L)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (DP1CA216873)
Article History
Received: 23 August 2020
Accepted: 31 March 2021
First Online: 6 May 2021
Competing interests
: B.E.B. discloses financial interests in Fulcrum Therapeutics, HiFiBio, Arsenal Biosciences, Cell Signaling Technologies and BioMillenia. The remaining authors declare no competing financial interests.